Elevated bone turnover in an infantile patient with mucolipidosis II; no association with hyperparathyroidism

Clinical Pediatric Endocrinology

Volumn 20, Issue 1, 2011, Pages 7-12

  Otomo, Takanobu ^a,b   Yamamoto, Takehisa ^a   Fujikawa, Yasuhiro ^a,c   Shimotsuji, Tsunesuke ^a   Ozono, Keiichi ^b  

^a Minoh City Hospital   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Fujikawa Pediatric Clinic   (Japan)

Author keywords

Bone formation; Bone resorption; Lysosome; Osteoclast; Parathyroid hormone

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA MANNOSIDASE; ARYLSULFATASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; DEOXYPYRIDINOLINE; DEOXYPYRIDOXINE; GENE PRODUCT; LYSOSOME ENZYME; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; PROCOLLAGEN TYPE I C PROPEPTIDE; PROTEIN GNPTAB; UNCLASSIFIED DRUG;

ARTICLE; BONE DENSITY; BONE RADIOGRAPHY; BONE TURNOVER; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE MUTATION; HUMAN; HYPERTHYROIDISM; INFANT; MALE; MICROGNATHIA; MUCOLIPIDOSIS TYPE 2; NEWBORN HEMOLYTIC DISEASE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; PERIOSTEUM; SKIN FIBROBLAST; URINARY EXCRETION;

EID: 79954536433     PISSN: 09185739     EISSN: 13477358     Source Type: Journal    
DOI: 10.1297/cpe.20.7     Document Type: Article

References (19)

1. Braulke T, Bonifacino JS. Sorting of lysosomal proteins. Biochim Biophys Acta 2009;1793:605-14.
2. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009;1793:664-73.
3. Otomo T, Higaki K, Nanba E, Ozono K, Sakai N. Inhibition of autophagosome formation restores mitochondrial function in mucolipidosis II and III skin fibroblasts. Mol Genet Metab 2009;98:393-9.
4. Tiede S, Storch S, Lübke T, Henrissat B, Bargal R, Raas-Rothschild A, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med 2005;11:1109-12.
5. Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta-subunits precursor gene. Am J Hum Genet 2006;78:451-63.
6. Kudo M, Bao M, D'Souza A, Ying F, Pan H, Roe BA, et al. The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA. J Biol Chem 2005;280:36141-9.
7. Raas-Rothschild A, Cormier-Daire V, Bao M, Genin E, Salomon R, Brewer K, et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J Clin Invest 2000;105:673-81.
8. Kornfeld S, Sly WS. I-cell disease and Pseudo-Hurler Polydystrophy: Disorders of lysosomal enzyme phosphorylation and localization. The Metabolic and Molecular Bases of Inherited Disease 2001;138:3469-82.
9. Pazzaglia UE, Beluffi G, Bianchi E, Castello A, Cori A, March A. Study of the bone pathology in early mucolipidosis II (I-cell disease). Eur J Pediatr 1989;148:553-7.
10. Unger S, Paul DA, Nino MC, McKay CP, Miller S, Sochett E, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005;164:236-43.
11. Grace DV, Julie B, Jenny A, Michael F, Janice F, Ravi S, et al. The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 2010;46:316-22.
12. Robinson C, Baker N, Noble J, King A, David G, Sillence D, et al. The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. J Inherit Metab Dis 2002;25:681-93.
13. Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008;22:129-48.
14. Demirel N, Aydin M, Zenciroglu A, Okumus N, Cetinkaya S, Yildiz YT, et al. Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress. Ann Trop Paediatr 2009;29:149-54.
15. Salle BL, Braillon P, Glorieux FH, Brunet J, Cavero E, Meunier PJ. Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr 1992;81:953-8.
16. Otomo T, Muramatsu T, Yorifuji T, Okuyama T, Nakabayashi H, Fukao T, et al. Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation. J Hum Genet 2009;54:145-51.
17. Faye-Petersen OM, Johnson WH Jr, Carlo WA, Hedlund GL, Pacifico AD, Blair HC. Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms. Pediatr Pathol Lab Med 1996;16:489-507.
18. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996;273:1236-9.
19. Ruivo R, Anne C, Sagné C, Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta 2009;1793:636-49.